Loading…
MS

M. Scott Furness

FDA, United States
Deputy Director, Office of New Drug Products, OPQ, CDER
Scott Furness, Ph.D., Deputy Director, ONDP, OPQ, joined CDER’s OPS/OGD in 2000, serving as a Chemistry reviewer and team leader. In 2007, he was named Director of the Division of Nonprescription Regulation Development in the Office of New Drugs’ (OND). During his time in OND, Dr. Furness led several initiatives to modernize the over-the-counter (OTC) monograph system in areas pertaining to biopharmaceutics and product quality. In 2013, he returned to OPS as the ONDQA Deputy Director for Operations, and he has been the Deputy Director of ONDP since the stand-up of OPQ in 2015. In addition to his Deputy Director duties, Dr. Furness is also the supervisor of the Environmental Assessment Team and the Botanical Review Team within ONDP.

My Speakers Sessions

Thursday, June 18
 

5:00pm EDT